Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat

European Journal of Pharmacology

Volumn 449, Issue 1-2, 2002, Pages 61-69

  Costa, Barbara ^a   Parolaro, Daniela ^b   Colleoni, Mariapia ^c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Anandamide; Brain, rat; Cannabinoid; Cytochrome P450; Liver, rat; Tolerance

Indexed keywords

ANANDAMIDE; CYTOCHROME B5; CYTOCHROME P450; CYTOCHROME P450 2B1; CYTOCHROME P450 2B2; CYTOCHROME P450 3A2; CYTOCHROME P450 REDUCTASE; ISOENZYME; UNSPECIFIC MONOOXYGENASE; AMIDE; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; BRAIN LEVEL; BRAIN MICROSOME; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; IMMUNOBLOTTING; IMMUNOREACTIVITY; LIVER LEVEL; LIVER MICROSOME; LONG TERM EXPOSURE; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; ANIMAL; BRAIN; ENZYMOLOGY; IN VITRO STUDY; MICROSOME; POLYACRYLAMIDE GEL ELECTROPHORESIS; SPRAGUE DAWLEY RAT; STIMULATION; TIME;

ANIMAL; ARACHIDONIC ACIDS; BRAIN; CYTOCHROME B5; CYTOCHROME P-450 ENZYME SYSTEM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOBLOTTING; IN VITRO; ISOENZYMES; MALE; MICROSOMES; MICROSOMES, LIVER; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL; TIME FACTORS; ANIMALS; CYTOCHROMES B5; ENDOCANNABINOIDS; POLYUNSATURATED ALKAMIDES;

EID: 0037008252     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01994-5     Document Type: Article

References (46)

1. Rat brain cytochrome P450: Catalytic, immunochemical properties and inducibility of multiple forms
2. The chronic administration of nicotine induces cytochrome P450 in rat brain
3. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells - Implications for cell proliferation and differentiation
4. Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol
5. Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: A possible member of the cytochrome P-450IIC subfamily
6. The effect of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism
7. Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol
8. Microsomal cytochrome P450-mediated liver and brain anandamide metabolism
9. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450
10. Cytochrome P450 and the arachidonate cascade
11. Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat
12. SR141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats
13. Precipitated and spontaneous withdrawal in rats tolerant to anandamide
14. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
15. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
16. Cannabimimetic fatty acid derivatives: The anandamide family and other "endocannabinoids"
17. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
18. 9-tetrahydrocannabinol-tolerant rats
19. 9-tetrahydrocannabinol
20. Studies on pig liver microsomes: I. Enzymic and pigment composition of different microsomal fractions
21. An improved assay of 7-ethoxycoumarin O-deethylase activity: Induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholantrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin
22. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration
23. Cannabidiol and cannabinol in man
24. Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis
25. Elevated endogenous cannabinoids in schizophrenia
26. Protein measurement with the Folin phenol reagent
27. Drug metabolizing enzymes in the brain and cerebral microvessels
28. Aromatization and 19-hydroxylation of androgens by rat brain cytochrome P450
29. Molecular characterization of a peripheral receptor for cannabinoids
30. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture
31. The carbon monoxide-binding pigment of liver microsomes: I. Evidence for its hemoprotein nature
32. 5 and NADPH-cytochrome c reductase from liver microsomes
33. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: First evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level
34. Distribution of cytochrome P450 activities towards alkoxyresorufin derivatives in rat brain regions, subcellular fractions and isolated cerebral microvessels
35. Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticudes
36. Xenobiotic metabolism in human brain - Presence of cytochrome P-450 and associated mono-oxygenases
37. Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: An in situ hybridization study
38. 35S]thiotriphosphate binding without receptor down-regulation in brain regions of anandamide-tolerant rats
39. Brain cytochromes P-450 are responsive to phenobarbital and tricyclic amines
40. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu 1 opioid receptor mechanism
41. Interaction of epinephrine metabolites with the liver microsomal electron transport system
42. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension
43. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
44. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymixyn B-selective adsorption and subsequent high-performance liquid chromatography analysis: Increase in endogenous cannabinoids in the sera of patients with endotoxic shock
45. Distribution and regulation of 5a-androstane-2b,17b-diol hydroxylase in the rat central nervous system
46. 5s in rat brain